CIPLA
Back to All Ratios
|
CIPLA Last 5 Year EV/EBIT History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EV/EBIT(x) | 17.27 | 22.52 | 19.16 | 15.12 | 20.62 |
What is the latest EV/EBIT ratio of CIPLA ?
Year | EV/EBIT |
---|---|
Mar2023 | 17.27 |
Mar2022 | 22.52 |
Mar2021 | 19.16 |
Mar2020 | 15.12 |
Mar2019 | 20.62 |
How is EV/EBIT of CIPLA Trending?
Years | EV/EBIT | % Change | |
---|---|---|---|
Mar2023 | 17.27 | -23.31 | |
Mar2022 | 22.52 | 17.54 | |
Mar2021 | 19.16 | 26.72 | |
Mar2020 | 15.12 | -26.67 | |
Mar2019 | 20.62 | - |
Other Financial Ratios of CIPLA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/EBIT ratio of peers of CIPLA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CIPLA | ₹114,925.3 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics | |
MANKIND PHARMA | ₹91,490.4 Cr | -4.2% | -4.7% | NA | Stock Analytics |
CIPLA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CIPLA | 1.1% |
-4.4% |
55.5% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses